WallStreetZenWallStreetZen

NASDAQ: COYA
Coya Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for COYA

Based on 4 analysts offering 12 month price targets for Coya Therapeutics Inc

Min Forecast
$14.00+138.5%
Avg Forecast
$16.50+181.09%
Max Forecast
$18.00+206.64%

Should I buy or sell COYA stock?

Based on 4 analysts offering ratings for Coya Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although COYA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates COYA as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their COYA stock forecasts and price targets.

COYA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-24
lockedlocked$00.00+00.00%2025-07-09
lockedlocked$00.00+00.00%2025-07-01
lockedlocked$00.00+00.00%2025-06-09

1 of 1

Forecast return on equity

Is COYA forecast to generate an efficient return?

Company
-96.73%
Industry
23.79%
Market
56.48%
COYA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is COYA forecast to generate an efficient return on assets?

Company
-84.05%
Industry
9.18%
COYA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COYA earnings per share forecast

What is COYA's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.49
Avg 2 year Forecast
-$1.93

COYA revenue forecast

What is COYA's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$5.5M+50.06%
Avg 2 year Forecast
$1.5M-59.3%
COYA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

COYA revenue growth forecast

How is COYA forecast to perform vs Biotechnology companies and vs the US market?

Company
50.06%
Industry
3,099.86%
Market
50.48%
COYA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
COYA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

COYA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COYA$5.87$16.50+181.09%Strong Buy
MGNX$1.54$3.25+111.04%Buy
ZNTL$1.38$8.00+479.71%Buy
NAUT$0.76N/AN/A
ADAG$2.01$8.00+298.01%Buy
View Top Biotech Stocks

Coya Therapeutics Stock Forecast FAQ

Is Coya Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: COYA) stock is to Strong Buy COYA stock.

Out of 4 analysts, 3 (75%) are recommending COYA as a Strong Buy, 1 (25%) are recommending COYA as a Buy, 0 (0%) are recommending COYA as a Hold, 0 (0%) are recommending COYA as a Sell, and 0 (0%) are recommending COYA as a Strong Sell.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.

What is COYA's earnings growth forecast for 2025-2026?

(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 51.94%.

Coya Therapeutics's earnings in 2025 is -$17,135,631.On average, 2 Wall Street analysts forecast COYA's earnings for 2025 to be -$24,920,247, with the lowest COYA earnings forecast at -$26,258,247, and the highest COYA earnings forecast at -$23,582,247.

In 2026, COYA is forecast to generate -$32,279,246 in earnings, with the lowest earnings forecast at -$32,279,246 and the highest earnings forecast at -$32,279,246.

What is COYA's revenue growth forecast for 2025-2026?

(NASDAQ: COYA) Coya Therapeutics's forecast annual revenue growth rate of 50.06% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 3,099.86%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 50.48%.

Coya Therapeutics's revenue in 2025 is $3,685,107.On average, 2 Wall Street analysts forecast COYA's revenue for 2025 to be $92,489,239, with the lowest COYA revenue forecast at $40,139,995, and the highest COYA revenue forecast at $144,838,483.

In 2026, COYA is forecast to generate $25,087,497 in revenue, with the lowest revenue forecast at $25,087,497 and the highest revenue forecast at $25,087,497.

What is COYA's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: COYA) forecast ROA is -84.05%, which is lower than the forecast US Biotechnology industry average of 9.18%.

What is COYA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year COYA price target, the average COYA price target is $16.50, with the highest COYA stock price forecast at $18.00 and the lowest COYA stock price forecast at $14.00.

On average, Wall Street analysts predict that Coya Therapeutics's share price could reach $16.50 by Jul 24, 2026. The average Coya Therapeutics stock price prediction forecasts a potential upside of 181.09% from the current COYA share price of $5.87.

What is COYA's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: COYA) Coya Therapeutics's current Earnings Per Share (EPS) is -$1.07. On average, analysts forecast that COYA's EPS will be -$1.49 for 2025, with the lowest EPS forecast at -$1.57, and the highest EPS forecast at -$1.41. In 2026, COYA's EPS is forecast to hit -$1.93 (min: -$1.93, max: -$1.93).

What is COYA's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: COYA) forecast ROE is -96.73%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.